Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
2,545.41
2,222.85
1,912.12
1,694.44
1,397.79
1,013.44
1,095.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,545.41
2,222.85
1,912.12
1,694.44
1,397.79
1,013.44
1,095.64
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
701.68
590.22
479.37
432.38
360.97
238.16
236.35
(Increase) / Decrease In Stocks
-9.38
-9.62
-3.95
-8.31
-6.07
2.15
3.51
Employee Cost
378.60
353.48
308.24
275.12
233.65
195.94
208.03
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
549.07
481.67
413.57
356.11
295.82
221.75
245.07
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
459.65
419.82
385.30
340.46
275.44
228.85
230.49
Total Expenditure (Excl Depreciation)
2,079.62
1,835.57
1,582.53
1,395.76
1,159.81
886.85
923.45
Operating Profit (PBDIT) excl Other Income
465.79
387.28
329.59
298.68
237.98
126.59
172.19
Other Income
24.99
34.81
16.94
13.18
12.67
16.95
6.97
Operating Profit (PBDIT)
490.78
422.09
346.53
311.86
250.65
143.54
179.16
Interest
176.57
154.56
108.74
103.50
97.77
119.17
137.65
Exceptional Items
-44.58
0.00
3.90
0.00
94.61
-93.45
0.00
Gross Profit (PBDT)
269.63
267.53
241.69
208.36
247.49
-69.08
41.51
Depreciation
244.17
211.34
174.36
163.47
158.28
159.22
148.45
Profit Before Tax
25.46
56.19
67.33
44.89
89.21
-228.30
-106.94
Tax
4.14
8.13
26.40
27.25
48.85
-7.56
6.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.32
48.06
40.93
17.64
40.36
-220.74
-113.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
21.32
48.06
40.93
17.64
40.36
-220.74
-113.13
Share in Profit of Associates
1.46
0.77
0.39
-0.02
-1.44
-0.36
-12.32
Minority Interest
-9.02
-4.42
6.82
11.72
14.81
27.64
18.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13.76
44.41
48.14
29.34
53.73
-193.46
-106.69
Equity Capital
149.30
139.42
139.29
139.12
139.01
125.36
88.69
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,182.67
783.03
686.49
721.41
731.28
571.82
292.56
Earnings per share (EPS)
0.92
3.17
3.46
2.11
3.87
-15.43
-12.03
Diluted Earnings per share
0.96
3.12
3.43
2.1
3.97
-17.02
-12.05
Operating Profit Margin (Excl OI)
18.35%
17.46%
17.28%
17.66%
17.06%
12.54%
15.72%
Gross Profit Margin
10.62%
12.06%
12.67%
12.32%
17.74%
-6.85%
3.79%
PAT Margin
0.9%
2.2%
2.17%
1.04%
2.79%
-21.91%
-11.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 14.51% vs 16.25% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -69.02% vs -7.75% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 20.27% vs 17.50% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 14.24% vs 42.14% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Health.Global With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,545.41
1,679.36
866.05
51.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,545.41
1,679.36
866.05
51.57%
Raw Material Cost
0.00
295.06
-295.06
-100.00%
Purchase of Finished goods
701.68
0.00
701.68
(Increase) / Decrease In Stocks
-9.38
0.75
-10.13
-1,350.67%
Employee Cost
378.60
323.40
55.20
17.07%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
549.07
257.07
292.00
113.59%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
459.65
358.76
100.89
28.12%
Total Expenditure (Excl Depreciation)
2,079.62
1,235.04
844.58
68.38%
Operating Profit (PBDIT) excl Other Income
465.79
444.32
21.47
4.83%
Other Income
24.99
31.61
-6.62
-20.94%
Operating Profit (PBDIT)
490.78
475.93
14.85
3.12%
Interest
176.57
58.89
117.68
199.83%
Exceptional Items
-44.58
0.00
-44.58
Gross Profit (PBDT)
269.63
417.04
-147.41
-35.35%
Depreciation
244.17
62.46
181.71
290.92%
Profit Before Tax
25.46
354.58
-329.12
-92.82%
Tax
4.14
81.03
-76.89
-94.89%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
21.32
273.56
-252.24
-92.21%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
21.32
273.56
-252.24
-92.21%
Share in Profit of Associates
1.46
0.00
1.46
Minority Interest
-9.02
-15.44
6.42
41.58%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13.76
258.12
-244.36
-94.67%
Equity Capital
149.30
86.39
62.91
72.82%
Face Value
10.00
2.00
0.00
Reserves
1,182.67
2,017.91
-835.24
-41.39%
Earnings per share (EPS)
0.92
5.98
-5.06
-84.62%
Diluted Earnings per share
0.96
6.87
-5.91
-86.03%
Operating Profit Margin (Excl OI)
18.35%
26.46%
0.00
-8.11%
Gross Profit Margin
10.62%
24.83%
0.00
-14.21%
PAT Margin
0.90%
16.29%
0.00
-15.39%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,545.41 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.51% vs 16.25% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 13.76 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -69.02% vs -7.75% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 465.79 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 20.27% vs 17.50% in Mar 2025
Annual - Interest
Interest 176.57 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.24% vs 42.14% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.35%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
